The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting of CD317 by the immunotoxin HM1.24-ETA’ to allow immunotherapy in glioblastoma patients.
 
Dorothee Gramatzki
No Relationships to Disclose
 
Emese Szabo
No Relationships to Disclose
 
Martin Gramatzki
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Novartis; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Roche
Research Funding - Amgen; Novartis
Travel, Accommodations, Expenses - Amgen; Celgene; Novartis
 
Matthias Peipp
No Relationships to Disclose
 
Michael Weller
Honoraria - Merck Serono; MSD; Novocure; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck Serono; Orbus Therapeutics; Pfizer; Teva; Tocagen
Research Funding - Bayer (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst); Tragara (Inst)